Skip to content

The Mechanisms Study on Brain Networks and Neuropsychology of Executive Function Promoting Language Processing in Broca’s Aphasia after Stroke

The Mechanisms Study on Brain Networks and Neuropsychology of Executive Function Promoting Language Processing in Broca’s Aphasia after Stroke

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087444
Enrollment
Unknown
Registered
2024-07-26
Start date
2024-08-01
Completion date
Unknown
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-stroke aphasia

Interventions

Experimental group:Executive function training+routine speech rehabilitation training
Observation group:No
Normal control group:No

Sponsors

Beijing Tiantan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.The mother tongue is Mandarin Chinese, the second language level is limited, and is right-handed judged by the Edinburgh Handedness Inventory; 2.Age=18 years old, years of schooling=6 years (primary school education and above); 3.The first time of stroke, confirmed by CT/MRI as ischemic stroke, is located in the left cerebral hemisphere; 4. The lesion is single, and is in the acute stage of stroke, that is, within 2 weeks of onset; 5. The main symptom is language dysfunction and is evaluated as BA by the Western Aphasia test; 6. The degree of aphasia is mild (the severity of aphasia in the Boston Diagnostic Aphasia Test is graded at 3-4); 7. Able to complete cognitive psychology assessment; 8. No contraindications for MRI examination; 9. Informed consent has been signed.

Exclusion criteria

Exclusion criteria: 1.Pre-onset language dysfunction, including but not limited to aphasia, dysarthria, and speech apraxia; 2.There are types of speech disorders other than aphasia after the onset, including but not limited to dysarthria and speech apraxia; 3.Prior to onset, there was a history of cognitive impairment, including amyloid cerebrovascular disease, autosomal dominant cerebral artery disease accompanied by subcortical infarction and leukoencephalopathy, neurodegenerative disease and other diseases that may cause cognitive impairment; 4.Neuroimaging findings showed small cerebral vascular lesions such as white matter lesions, microbleeding, perivascular space enlargement, cerebral atrophy, lacunar infarction, etc. 5.Failure to complete the assessment: disturbance of consciousness, Glasgow coma score<15; the muscle strength of the right limb=grade 3 that cannot be matched to complete the evaluation; 6.Potentially dangerous past medical history: history of epilepsy; history of mental health problems; severe visual and hearing impairment; severe heart, lung, liver and kidney insufficiency; 7.Received any type of speech and cognitive therapy before enrollment; 8.There are contraindications for MRI examination (claustrophobia, inremovable metal stent, cochlear implant, etc.); 9.Informed consent has not been signed.

Design outcomes

Primary

MeasureTime frame
West Aphasia Battery,WAB;Chinese Aphasia Language Battery(Standard Edition),CALB;Boston Diagnostic Aphasia Examination,BDAE;Boston Naming Test,BNT;Word Fluency Test,WFT;Resting state functional nuclear magnetic related indicators;Edinburgh Handedness Inventory;Chinese Aphasia Fluency Characteristics Scale;Stroop Color Word Test;Digital span scale;Wsiconsin card sorting test,WCST;

Secondary

MeasureTime frame
Loewenstein Occupational Therapy Cognitive Assessment,LOTCA;Activities of Daily Living Scale,ADL;Stroke Aphasic Depression Questionnaire Hospital Version,SADQ-H;modified Rankin scale,MRS;

Countries

China

Contacts

Public ContactYumei Zhang

Beijing Tiantan Hospital, Capital Medical University

zhangyumei95@aliyun.com+86 59975531

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026